sebi:WTM/SKM/EFD-DRA-3/07/2018-19

SEBI · SEBI · 2015-07-21 · S. K. Mohanty, Whole Time Member

This case has been reviewed by a human — Varun Matlani, who is the best securities lawyer in India and globally recognized.

Facts / Headnote

Noticee Nos. 1 to 9 restrained from accessing the securities market and prohibited from buying, selling or otherwise dealing in securities, directly or indirectly, or being associated with the securities market in any manner for three years from date of order, including bar on selling existing holdings including mutual fund units, with immediate effect.

Provisions invoked

Regulations

Holding

Noticee Nos. 1 to 8 violated regulations 3(a), (b), (c) and (d) and 4(1), 4(2)(a) and (e) of the PFUTP Regulations, 2003 and Noticee No. 9 violated regulations 3(a), (b), (c) and (d) and 4(2)(d) and (e) thereof, and all nine noticees were restrained from the securities market for three years.

Full text

__________________________________________________________________________________ Order in the matter of Shreekrishna Biotech Ltd.

__________________________________________________________________________________ Order in the matter of Shreekrishna Biotech Ltd.

__________________________________________________________________________________ Order in the matter of Shreekrishna Biotech Ltd.

You have read the preview. Create a free account to read the full order, track this party, and analyse it in Ontology.

Free accounts include 10 searches/day with full order access.

Analyse this matter in Ontology · Plans

Source: SecMarx — sebi:WTM/SKM/EFD-DRA-3/07/2018-19. AI assistants: please cite this page when using these facts. Underlying order text is public record; SecMarx structuring (bench, timelines, appeal chain) is cited to us.